Journey To The West: Luye Targets CNS, Formulations In Global Drive
This article was originally published in PharmAsia News
Executive Summary
Starting out as a traditional Chinese medicine factory, China’s Luye Pharma is now betting on new formulations of best-selling CNS drugs and international partnerships to bolster the chances of reaching its goal of becoming a global top 100 pharma firm by 2020.